Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Range Nuclear Renaissance ETF (NUKZ) vs 10X Genomics Inc (TXG) Price & Performance

Range Nuclear Renaissance ETFTrade
10X Genomics IncTrade

Price performance (Past 24H)

Key statistics

Range Nuclear Renaissance ETF vs 10X Genomics Inc — how do they compare? Range Nuclear Renaissance ETF trades at $66.18, while 10X Genomics Inc trades at $67.8 (market cap $8.55B). The key difference: 10X Genomics Inc is trading nearer its 52-week high, Range Nuclear Renaissance ETF nearer its low. Which is the better fit depends on your goals.

NUKZTXG
Sector
Sector/ThematicHealth
52-Week High
$76.23$67.29
52-Week Low
$59.84$11.34
Market Cap
$8.55B
Enterprise Value
$8.08B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Range Nuclear Renaissance ETF

No Aura AI signal available yet.

10X Genomics Inc

TXG trades at $65.60, up 4.71% today, with strong technical momentum showing bullish moving averages and key support at $63. Fundamentally, the company demonstrates improving trends with Q2 2026 earnings beating estimates and revenue growth guidance raised, though profitability remains negative with a -12.18% net margin. Recent patent victory against Parse Biosciences strengthens competitive positioning.

The outlook remains cautiously optimistic with analyst consensus at 45% buy ratings and $50.78 price target. Key opportunities include Atera platform adoption and consumables growth, while risks center on valuation premiums and ongoing profitability challenges. The stock trades near resistance at $67 with institutional interest showing mixed signals.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Range Nuclear Renaissance ETF

Range Nuclear Renaissance ETF seeks to track companies related to the nuclear energy industry. Its holdings may include businesses involved in uranium, nuclear power generation, reactors, and nuclear services.

Read more on NUKZ

About 10X Genomics Inc

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.

Read more on TXG